SCHEMBL6693899

SCHEMBL6693899

FC(F)(F)c1cc(NCc2cccc(Cl)c2)cc(NCc2cccc(Cl)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 2/20 0.54
FABP4 P15090 1/20 0.49
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TRPA1 O75762 1/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CHRM2 P08172 1/20 0.45
FFAR1 O14842 1/20 0.45
FFAR4 Q5NUL3 1/20 0.45
GRIN2B Q13224 1/20 0.45
NOS2 P35228 1/20 0.45
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6695951 0.91 P2RX1 (0.46) P2RX1FABP4MEN1KMT2AMAPT
SCHEMBL6694928 0.89 P2RX1 (0.45) P2RX1FABP4MEN1KMT2AMAPT
SCHEMBL6693479 0.88 MEN1 (0.59) P2RX1MEN1KMT2AMAPTHTT
SCHEMBL631859 0.83 MEN1 (0.55) MEN1KMT2AMAPTHTTNPSR1
SCHEMBL6700054 0.81 CHRM2 (0.55) MEN1KMT2AMAPTALDH1A1CHRM2
SCHEMBL5226860 0.78 FFAR1 (0.61) MEN1KMT2AMAPTHTTNPSR1
SCHEMBL632217 0.78 CHRM2 (0.55) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL6693473 0.78 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1CHRM2
SCHEMBL3305997 0.76 MYC (0.74) MEN1KMT2AMAPTHTTNPSR1
SCHEMBL11510712 0.76 HDAC4 (0.54) MEN1KMT2ACYP1A2CYP2C19CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups 4SC AG (DE) 2004-01-15 US disclosed
WO-2003076388-A2 BIS-ANILINE DERIVATIVES USEFUL AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2003-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups PAH, PNMT, OPRM1 P2RX1 1634/4885FABP4 4215/4885MEN1 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.